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Abstract
Objective: The aim of this study was to evaluate whether a change in the routine feeding strategy
applied after pancreatoduodenectomy (PD) from nasojejunal tube (NJT) feeding to early oral feeding
improved clinical outcomes.
Methods: An observational cohort study was performed in 102 consecutive patients undergoing PD. In
period 1 (n = 51, historical controls), the routine postoperative feeding strategy was NJT feeding. This was
changed to a protocol of early oral feeding with on-demand NJT feeding in period 2 (n = 51, consecutive
prospective cohort). The primary outcome was time to resumption of adequate oral intake.
Results: The baseline characteristics of study subjects in both periods were comparable. In period 1,
98% (n = 50) of patients received NJT feeding, whereas in period 2, 53% (n = 27) of patients did so [for
delayed gastric empting (DGE) (n = 20) or preoperative malnutrition (n = 7)]. The time to resumption of
adequate oral intake significantly decreased from 12 days in period 1 to 9 days in period 2 (P = 0.015),
and the length of hospital stay shortened from 18 days in period 1 to 13 days in period 2 (P = 0.015).
Overall, there were no differences in the incidences of complications of Clavien–Dindo Grade III or higher,
DGE, pancreatic fistula, postoperative haemorrhage and mortality between the two periods.
Conclusions: The introduction of an early oral feeding strategy after PD reduced the time to resumption
of adequate oral intake and length of hospital stay without negatively impacting postoperative morbidity.
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Introduction
Pancreatoduodenectomy (PD) is the treatment of choice for
resectable (pre-)malignant neoplasms in the pancreatic head or
periampullary region.1 Although postoperative mortality rates
have decreased over recent decades,2 PD is still associated with
significant morbidity, including a 33–45% incidence of delayed
gastric emptying (DGE),3–5 which interferes with the resumption
of a normal diet after surgery and frequently results in the need for
nutritional support and a prolonged hospital stay.6
Some studies have suggested that enteral nutrition after PD
reduces hospital length of stay (LoS), readmission rates and com-
plication rates.7–9 The guidelines of the European Society for Par-
enteral and Enteral Nutrition (ESPEN) recommend the routine
use of early enteral nutrition in all patients undergoing major
gastrointestinal resections for cancer.10 By contrast, the current
American Society of Parenteral and Enteral Nutrition (ASPEN)
guidelines recommend the use of on-demand postoperative
nutritional support.11 In addition, a recent systematic review sug-
gested that oral feeding, with on-demand nasojejunal tube (NJT)
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feeding, is the most appropriate routine feeding strategy after PD
because it is at least non-inferior to enteral and parenteral nutri-
tion in terms of hospital LoS and risk for complications.12
Furthermore, nasoenteral and parenteral feeding strategies are
associated with specific complications, including the dislodge-
ment of NJTs in a third of patients, bowel strangulation and
perforation following percutaneous jejunostomy (albeit rarely)
and, in cases of parenteral nutrition, an up to twice as high risk for
infectious complications.13–17 However, studies directly comparing
early oral feeding with routine NJT feeding after PD are lacking.
The discrepancy in views on the optimal routine feeding strat-
egy after PD (routine versus on-demand nasoenteral feeding) and
the lack of evidence to support routine (par)enteral nutrition after
PD led the study institution to change its feeding protocol from
routine NJT feeding to an early oral feeding strategy with
on-demand NJT feeding. The aim of this study was to evaluate
whether this change in the routine postoperative feeding strategy
improved outcomes.
Materials and methods
Patients
An observational, non-randomized, prospective cohort study
with historical controls was performed in 111 consecutive patients
undergoing PD at the University Medical Centre Utrecht from
June 2010 to December 2012. A subset of these patients (n = 20)
has been described in a previous study.13 Included were adult
patients undergoing any of classic Whipple PD, pylorus-
preserving PD or total pancreatectomy for any indication.
Excluded were all patients who underwent PD in the transition
period (October–December 2011), during which the new early
oral feeding strategy was introduced on the ward (n = 9). In this
transition period, all nurses and treating physicians attended a
training session conducted by the study coordinator and the
department’s dietician to explain the standardized early oral
feeding protocol. To further improve adherence, the protocol was
made available to all nurses and physicians on a plastic card on the
ward. No other changes in surgical or medical treatment strategy
(e.g. surgical technique, erythromycin use) that might influence
outcomes were introduced during the entire study period. Patients
were categorized into two groups based on the period in which
they underwent surgery and thereby the routine feeding protocol
to which they were subjected.
Period 1: Routine NJT feeding
In period 1 (June 2010 to September 2011), the routine postop-
erative feeding strategy was NJT feeding. Enteral nutrition was
delivered via a NJT (Freka Trelumina tube; Fresenius Kabi Ltd,
Runcorn, UK), which was placed in the jejunum during PD. The
tube was introduced by the anaesthesiologist through the nose,
into the stomach and advanced for ≥30 cm through the duodeno-
or gastrojejunostomy into the efferent limb after the creation of
the dorsal part of this anastomosis. The tube was secured to the
nostrils with tape. The patency of the tube was tested before the
abdomen was closed. Enteral nutrition (NV Nutricia, Zoetermeer,
the Netherlands) was started on the first postoperative morning at
a rate of 25 ml/h and increased by 25 ml per 6 h to the amount
advised by the consulting dietician according to national guide-
lines.18 In the event of dislodgement of the NJT, the tube was
replaced only when oral intake in the following days was expected
to be inadequate.
Oral intake was started depending on digestive symptoms.
When oral intake was adequate, enteral nutrition was discon-
tinued. The NJT was removed at this stage.
Period 2: Early oral feeding strategy
The early oral feeding strategy implemented in period 2 (January–
December 2012) involved the resumption of oral intake as per the
feeding protocol. Patients were started on oral feeding immedi-
ately after surgery and were given liquid drinks from day 0 (day of
surgery), solid food from day 2 and a regular diet from day 3. Oral
nutritional supplements given twice per day (200 ml Nutridrink
Protein; NV Nutricia) were initiated on day 2 and discontinued at
discharge.
Oral intake was recorded daily and evaluated on days 4 and 7 by
the consulting dietician. When oral intake was insufficient on
postoperative day 7 (<50% of the required daily calorie/protein
intake as calculated by the dietician), a NJT was endoscopically
placed (on demand) and enteral nutrition was administered until
oral intake was adequate.
In patients who were found to suffer from malnutrition at
preoperative screening, a NJT was placed during PD to enable the
provision of postoperative enteral nutrition according to the
protocol followed in period 1. According to the intention-to-treat
principle, these patients were included in the early oral feeding
strategy group (period 2). Oral feeding was initiated simulta-
neously according to the early oral feeding protocol, but no oral
nutritional supplements were given.
Preoperative management
In both periods, all patients were preoperatively screened for mal-
nutrition in the outpatient department by trained nurses using
the Malnutrition Universal Screening Tool (MUST)19 and were
informed about the postoperative feeding strategy. In the event of
malnutrition [defined by a MUST score of ≥2, a body mass index
(BMI) of <18.5 kg/m2 and/or severe preoperative weight loss],
patients were referred to a dietician and started on preoperative
nutritional support, including oral nutritional supplements or
enteral nutrition, if possible, at least 14 days before surgery.
Surgical approach
The surgical approach was identical in both periods.
Pancreaticoduodenectomy was performed by a team specializing
in hepatobiliary and pancreatic surgery. Reconstruction was
performed with an end-to-side, duct-to-mucosa pancreatoje-
junostomy [International Study Group of Pancreatic Surgery
(ISGPS) type IAS020] over a 6-cm, 6-Fr stent, end-to-side
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hepaticojejunostomy and antecolic end-to-side duodenoje-
junostomy (pylorus-preserving PD) or antecolic gastrojejunos-
tomy combined with a Roux-en-Y reconstruction (Whipple
procedure).
Postoperative management
Postoperative management was similar in both periods. Early
postoperative analgesia was achieved epidurally or, when
contraindicated or when epidural placement was not successful,
by i.v. patient-controlled analgesia. Nasogastric tubes were
removed on day 1 unless the drainage amount per 24 h was
>300 ml. In such cases, the tube was removed when the drainage
amount per 24 h dropped to <300 ml. Patients were mobilized out
of bed from day 1 under the guidance of a physiotherapist or
nurse. Peripancreatic drains were removed when the drainage
amount per 24 h was <50 ml and amylase content was less than
three times the upper normal serum value (measured on days 1, 3
and 5). Total parenteral nutrition (TPN) was started only when
enteral feeding was unsuccessful or contraindicated. Patients were
discharged when they were fully mobile (i.e. they had achieved
autonomous activity or returned to their preoperative level of
activity), oral intake was adequate and there was no evidence of
local or systemic complications.
Definitions
All postoperative complications were graded according to the
Clavien–Dindo system of classification.21 The postoperative
course was defined as complicated if a complication occurred that
required any form of intervention (Clavien–Dindo Grade III or
higher). Both postoperative NJT placement and NJT replacement
after dislodgement were graded as representing a Clavien–Dindo
Grade III incident. Postoperative pancreatic fistula, DGE and
post-pancreatectomy haemorrhage were defined according to
ISGPS definitions.22–24 Cancer stage was defined according to the
7th edition of the American Joint Committee on Cancer (AJCC)
staging system.25 Severe preoperative weight loss was defined as
unintentional weight loss of ≥10% of body weight within 6
months or ≥5% of body weight within 1 month prior to presen-
tation at the outpatient department. Oral intake was defined as
adequate when it exceeded 50% of the daily required caloric
intake with an upward trend, or when it was reported as adequate
by the treating physician or dietician. Tube dislodgement was
defined as the displacement of the tip of the feeding tube into D2
or more proximally in the gastrointestinal tract, making the con-
tinuation of tube feeding unsafe or impossible.
Data collection
From 1 January 2012 (period 2), data were prospectively collected
and entered into an electronic database. Prior to this date (period
1), data were retrospectively collected from computerized clinical
records and daily notes. Baseline characteristics collected were
patient age, sex, American Society of Anesthesiologists (ASA)
physical status, BMI,MUST score, severe preoperative weight loss,
preoperative dietary intervention, histopathological diagnosis,
cancer stage and type of procedure.
Outcomes
The primary outcome was time to resumption of adequate oral
intake. Secondary outcomes were time to start of oral and solid
food intake, TPN use, duration of (par)enteral nutrition, use of
prokinetic agents, weight loss during admission, postoperative
surgical, general and tube-related complications (in-hospital and
during readmission), incidence of postoperative pancreatic
fistula, DGE, post-pancreatectomy haemorrhage, length of hospi-
tal and intensive care unit (ICU) stays, readmission within 30 days
after discharge and in-hospital mortality.
Statistical analysis
Sample size was based on the number of eligible patients treated
according to the early oral feeding strategy in a 1-year period
(2012, period 2). These patients were compared with a control
group, which included an equal number of eligible patients who
were treated before the implementation of the new feeding strat-
egy (period 1).
Analyses were performed according to intention to treat,
meaning that there were no crossovers between groups. Values are
expressed as the median and interquartile range (IQR), unless
specified otherwise. Data were analysed using IBM spss Statistics
for Windows Version 20 (IBM Corp., Armonk, NY, USA). Con-
tinuous non-normally distributed variables were compared using
the Mann–Whitney U-test. Categorical variables were compared
using the chi-squared test or Fisher’s exact test as appropriate. For
multivariable analysis, a binary logistic regression model was
used. A two-tailed P-value of <0.05 was considered to indicate
statistical significance. To assess the presence of any potential
negative effects of early oral feeding in patients with a complicated
postoperative course, subgroup analyses for the main nutritional
and hospitalization parameters were performed in patients with
(and without) a complicated postoperative course, DGE and pan-
creatic fistulae. An additional subgroup analysis was performed in
period 2 based on the placement of a NJT in order to assess
whether patients who eventually required NJT feeding in period 2
were disadvantaged by the early oral feeding strategy.
Results
Patients
Between January and December 2012 (period 2), 51 patients
underwent PD with routine postoperative early oral feeding
including on-demand NJT feeding. Another 51 consecutive
patients who underwent PD with routine postoperative NJT
feeding between June 2010 and September 2011 (period 1) served
as historical controls. Baseline characteristics of patients did not
differ between the periods (Table 1).
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Efficacy
In period 2, postoperative time to the resumption of adequate oral
intake decreased by 3 days and hospital LoS decreased by 5 days
(Table 2).
Reasons for NJT feeding in period 2 (n = 27) were DGE in
20 patients and preoperative malnutrition in seven patients. In
patients with DGE, NJT feeding was initiated after a median of 7
days (IQR: 4–8 days). Seven patients in whom additional postop-
erative nutrition was indicated by signs of preoperative malnutri-
tion (see definition in Materials and methods) did not receive a
NJT during PD for logistical reasons (e.g. the correct feeding tube
was not available). Three of these patients received NJT feeding
secondarily after 1, 2 and 5 days, respectively, and were discharged
after a median of 15 days (IQR: 11–31 days). The other four
patients were discharged without ever having received enteral
nutrition after a median of 8 days (IQR: 6–11 days).
Complications
Morbidity and mortality rates are shown in Table 3. Overall mor-
bidity requiring intervention (Clavien–Dindo Grade III or higher)
and mortality did not differ between the periods.
The incidence of dislodgement of a primarily placed NJT sig-
nificantly decreased from 43% of patients in period 1 to 20% in
period 2. As only 27 patients in period 2 received a NJT, the rates
of dislodgement of primarily placed tubes were similar in both
periods [22 of 50 tubes (44%) in period 1 and 10 of 27 tubes
(37%) in period 2; P = 0.554].
Subgroup analyses
Results of subgroup analyses in patients with and without an
uncomplicated postoperative course, DGE and pancreatic fistulae
are shown in Table 4.
Table 1 Baseline characteristics of the study cohort
Period 1 Period 2 P-value
Routine NJT
feeding
Early oral feeding with
on-demand NJT feeding
(n = 51) (n = 51)
Male, n (%) 36 (71%) 29 (57%) 0.149
Age, years, median (IQR) 65 (58–74) 67 (63–74) 0.223
Body mass index, kg/m2, median (IQR) 24.7 (21.9–26.9) 25.8 (23.3–28.4) 0.061
MUST score ≥2, n (%) 7 (17%) 12 (26%) 0.308
Severe weight loss, n (%) 21 (41%) 18 (36%) 0.539
Preoperative dietary intervention, n (%) 17 (33%) 25 (49%) 0.108
Preoperative enteral nutrition, n (%) 6 (12%) 5 (10%) 0.750
ASA class, n (%) 0.103
1 12 (24%) 16 (31%)
2 34 (67%) 24 (47%)
3 5 (10%) 11 (22%)
AJCC cancer stage ≥IIa, n (%) 38 (75%) 43 (84%) 0.221
Histopathological diagnosis, n (%) 0.844
Pancreatic adenocarcinoma 20 (39%) 25 (49%)
Ampullary adenocarcinoma 9 (18%) 9 (18%)
Cholangiocarcinoma 8 (16%) 5 (10%)
Duodenal adenocarcinoma 1 (2%) 2 (4%)
Neuroendocrine tumour 4 (8%) 4 (8%)
Pancreatitis 5 (10%) 2 (4%)
Other 4 (8%) 4 (8%)
Procedure, n (%) 0.621
Pylorus-preserving PD 37 (73%) 33 (65%)
Whipple PD 2 (4%) 5 (10%)
Total pancreatectomy 1 (2%) 2 (4%)
PD with additional resection 11 (22%) 11 (32%)
NJT, nasojejunal tube; IQR, interquartile range; MUST, Malnutrition Universal Screening Tool; ASA, American Society of Anesthesiologists; AJCC,
American Joint Committee on Cancer; PD, pancreatoduodenectomy.
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Results of subgroup analyses regarding NJT feeding are shown
in Table 5. There was no significant difference in hospital LoS
between patients in period 1 [median LoS: 18 days (IQR: 12–30
days)] and the 20 patients (39%) in period 2 who eventually
required NJT feeding [median LoS: 22 days (IQR: 14–42 days)]
(P = 0.303). In patients who did not require NJT feeding in period
2, hospital LoS was significantly reduced by 9 days [median LoS: 9
days (IQR: 7–11 days)] in comparison with patients in period 1
[median LoS: 18 days (IQR: 12–30 days)] (P ≤ 0.001).
Multivariable analysis
A multivariable logistic regression analysis that adjusted for dif-
ferences in age, gender, BMI, MUST score of ≥2, ASA class of ≥3
and cancer stage of ≥II found no difference between the two
periods in rates of morbidity [Clavien–Dindo Grade III or higher:
odds ratio (OR) 0.96, 95% confidence interval (CI) 0.38–2.44] or
mortality (OR 0.13, 95% CI 0.00–9.44). Male patients had a
greater risk for developing morbidity than female patients (OR:
2.81, 95% CI 1.04–7.59; P = 0.041). No independent factors for
mortality were found.
Discussion
In the present study, the introduction of an early oral feeding
strategy after PD was found to have significantly reduced the time
to resumption of adequate oral intake and hospital LoS, without
increasing morbidity or readmission rates. Early oral feeding was
not associated with noticeable downturns in patients who even-
tually required NJT feeding or in patients with a complicated
postoperative course (e.g. DGE).
This study focused on the impact of introducing a single facet
of a fast-track or enhanced recovery after surgery (ERAS) protocol
after PD, namely, early oral feeding. Although previous studies
have supported early oral feeding after PD, these studies assessed
the impact of introducing a wide range of new measures in ERAS
programmes, rather than just the impact of early oral feeding and
thus do not make clear the actual impact of early oral feeding.26–29
Table 6 shows the postoperative oral feeding protocol applied in
the present study in comparison with the protocols applied in
previous studies. All previous studies reported a reduction in LoS
without an increase in complications. The traditional feeding
protocols used in the control groups in these previous studies
were, however, either ill defined or included both oral and enteral
feeding.27–29 Only one of these studies, an observational single-
surgeon study, compared the clinical outcomes of patients in
whom an enhanced recovery programme including early oral
feeding after PD was implemented (n = 20) with outcomes in a
control group subjected to routine NJT feeding (n = 24).26 The
The enhanced recovery programme was associated with an earlier
return to a liquid and solid diet, reduced hospital LoS and a
decreased readmission rate, without any increase in the incidence
of morbidity in comparison with the control group. When these
results are compared with those of the present study, it seems that
early oral feeding is especially responsible for these improvements.
Notably, one retrospective cohort study, which compared 152
patients who received routine NJT feeding with 123 controls who
received non-protocolized oral feeding between 2000 and 2009,
suggested that routine NJT feeding is superior in terms of time to
resumption of oral intake, and incidences of DGE and postopera-
tive haemorrhage, but not in terms of LoS.9 However, in this study,
the routine feeding strategy changed from one of oral feeding to
one of routine enteral nutrition, which represents an opposite
change to that implemented in the present study. Moreover, oral
feeding was non-protocolized and thus is likely to have carried a
Table 2 Nutritional and hospitalization parameters
Period 1 Period 2 P-value
Routine NJT
feeding
Early oral feeding with
on-demand NJT feeding
(n = 51) (n = 51)
Postoperative nutritional parameters
Time to adequate oral intake, days, median (IQR) 12 (10–18) 9 (6–20) 0.013
Enteral nutrition use, n (%) 50 (98%) 27 (53%) <0.001
Duration of enteral nutrition, days, median (IQR) 8 (6–13) 10 (5–20) 0.638
Parenteral nutrition use, n (%) 21 (41%) 13 (26%) 0.093
Duration of parenteral nutrition, days, median (IQR) 13 (7–23) 16 (7–25) 0.972
Use of prokinetics, n (%) 22 (43%) 27 (53%) 0.322
Postoperative weight/preoperative weight, %, median (IQR) 103 (97–106) 98 (96–103) 0.092
Hospitalization parameters
Length of stay, days, median (IQR) 18 (12–28) 13 (9–24) 0.015
Intensive and medium care unit stay, days, median (IQR) 1 (1–4) 1 (1–3) 0.574
Readmission within 30 days, n (%) 4 (8%) 7 (14%) 0.338
P-values shown in bold indicate statistical significance (P < 0.05).
NJT, nasojejunal tube; IQR, interquartile range.
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risk for suboptimal and uncoordinated treatment, whereas the
feeding strategy in the present study was protocolized and was
supervised by dieticians in both periods.
The overall hospital LoS in the present study was relatively long
in comparison with the 10–13 days generally reported.30–32 This
may be explained by the fact that the present study group had not
yet implemented a formal ERAS strategy in this study population
because the protocol involved a change in the feeding strategy
specifically, rather than a change in the entire postoperative man-
agement strategy.
The conventional reluctance to initiate early oral feeding prob-
ably arises from the fear of an increased risk for postoperative
complications; for example, the stimulation of pancreatic secre-
tion may increase the risk for pancreatic fistula and gastric stasis
due to DGE leading to aspiration.However, these concerns are not
substantiated by the findings of the present study, nor of those of
a recent systematic review of five feeding strategies after PD,which
found no relevant differences in the incidence of pancreatic fistula
between oral and (par)enteral feeding groups.12 By contrast, com-
plications related to (par)enteral nutrition, such as the frequent
dislodgement of NJTs, are well known.13–17 In the present study,
44% of NJTs placed during PD (period 1) became dislodged after
a median of only 8 days. The fact that only a third of dislodged
tubes required replacement can be seen to represent a further
argument in favour of the ‘on-demand’ strategy for NJT feeding
after PD. An early oral feeding strategy might therefore prevent
unnecessary tube placement. This study also demonstrated that an
early oral feeding strategy does not lead to unfavourable outcomes
Table 3 Morbidity and mortality
Period 1 Period 2 P-value
Routine NJT
feeding
Early oral feeding with
on-demand NJT feeding
(n = 51) (n = 51)
Overall morbidity, n (%)
Clavien–Dindo Grades I–V 46 (90%) 35 (69%) 0.007
Clavien–Dindo Grade III or higher 24 (47%) 23 (45%) 0.843
Surgical morbidity, n (%) 45 (88%) 32 (63%) 0.003
Delayed gastric emptying (grade B/C) 16 (31%) 18 (35%) 0.674
Pancreatic fistula (grade B/C) 6 (12%) 6 (12%) 0.999
Postoperative haemorrhage (grade B/C) 6 (12%) 5 (10%) 0.750
Surgical site infection 21 (41%) 12 (24%) 0.090
Intra-abdominal abscess 4 (8%) 6 (12%) 0.505
Anastomotic bowel leak 4 (8%) 5 (10%) 0.999
Chyle leak 8 (16%) 5 (10%) 0.539
Fascial dehiscence 6 (12%) 6 (12%) 0.999
Other surgical complications 7 (14%) 4 (8%) 0.338
General morbidity, n (%) 22 (43%) 22 (43%) 0.999
Infections
Cholangitis 4 (8%) 0 0.118
Line infection 3 (6%) 3 (6%) 0.999
Urinary tract infection 6 (12%) 1 (2%) 0.112
Pneumonia 10 (20%) 6 (12%) 0.276
Other general complications 13 (26%) 17 (33%) 0.385
Tube-related morbidity 24 (47%) 13 (26%) 0.023
Dislodgement of primary placed tube, n (%) 22 (43%) 10 (20%) 0.010
Day of dislodgement, median (IQR) 8 (5–12) 6 (3–7) 0.077
Requiring replacement, n (%) 8 (16%) 7 (14%) 0.780
Disabling blockage, n (%) 3 (6%) 4 (8%) 0.999
Other tube-related complicationsa, n (%) 0 1 (2%) 0.999
Mortality, n (%) 3 (6%) 1 (2%) 0.617
aNasal pressure ulcer.
P-values shown in bold indicate statistical significance (P < 0.05).
NJT, nasojejunal tube; IQR, interquartile range.
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in patients who eventually do require NJT feeding. The present
authors found no significant difference in hospital LoS between
patients who received routine NJT feeding in period 1 and the
39% of patients in period 2 who eventually required the insertion
of a NJT (18 days versus 22 days).
In patients who received routine early oral feeding, there was a
trend towards less TPN use, which is favourable as TPN is associ-
ated with an increased risk for infection.33 By contrast, other
studies comparing enteral nutrition [via a (gastro)jejunostomy
tube] with oral feeding after PD have reported an increase in TPN
in the latter group.7,8 In these patients, however, TPN was started
directly if oral intake was insufficient without using enteral nutri-
tion first.
The main limitation of the present study concerns the compari-
son of retrospective and prospective data. Selection bias may not
have played a relevant role as patients in both periods represent
consecutive cohorts. This assumption is supported by the absence
of differences in baseline patient characteristics such as age, ASA
physical status and cancer stage. There is, however, a clear risk for
information bias in period 1 (with retrospective data collection),
but such a bias would normally lead to the under-reporting of
complications and thus a better outcome in period 1. Interest-
ingly, as the rate of complications is actually slightly lower in
period 2, information bias is unlikely to have had a relevant
impact on the outcomes of this study. In addition, discharge cri-
teria were not changed during the study period. Whether or not
the study carries a high risk for performance bias is arguable
because postoperative instructions to patients, regarding the
resumption of oral intake, differed between the two periods. These
instructions (e.g. encouraging the early introduction and increase
of oral intake in period 2) are, however, an important element of
the intervention under investigation and thus one of the positive
aspects of the early oral feeding strategy.
In addition, although its cohort was larger than that in the only
previous study to have compared early oral feeding with routine
NJT feeding,26 this study included a relatively small sample and
therefore lacks the necessary power to prove true superiority of
early oral feeding. Future research should ideally include a high-
quality, randomized controlled trial to confirm the positive
impact of an early oral feeding strategy, with on-demand NJT
Table 4 Subgroup analyses: nutritional and hospitalization parameters in patients with and without complications, delayed gastric emptying
or pancreatic fistula
Complication not present Complication present
Period 1 Period 2 P-value Period 1 Period 2 P-value
Routine NJT
feeding
Early oral
feeding with
on-demand
NJT feeding
Routine NJT
feeding
Early oral
feeding with
on-demand
NJT feeding
Overall morbidity (Clavien–Dindo Grades III and higher) (n = 27) (n = 28) (n = 24) (n = 23)
Time to adequate oral intake, days, median (IQR) 11 (9–14) 6 (4–8) <0.001 14 (11–37) 21 (14–33) 0.412
Length of stay, days, median (IQR) 15 (11–20) 9 (8–13) <0.001 22 (17–48) 26 (14–46) 0.774
Delayed gastric emptying (grade B/C) (n = 35) (n = 33) (n = 16) (n = 18)
Time to adequate oral intake, days, median (IQR) 11 (9–14) 7 (5–9) <0.001 19 (14–53) 25 (14–44) 0.798
Length of stay, days, median (IQR) 17 (11–26) 9 (8–14) <0.001 24 (16–53) 30 (22–54) 0.721
Pancreatic fistula (grade B/C) (n = 45) (n = 45) (n = 6) (n = 6)
Time to adequate oral intake, days, median (IQR) 12 (10–16) 8 (6–14) 0.002 32 (13–70) 37 (19–81) 0.699
Length of stay, days, median (IQR) 18 (11–26) 11 (9–18) 0.007 50 (24–70) 49 (22–85) 0.999
P-values shown in bold indicate statistical significance (P < 0.05).
NJT, nasojejunal tube; IQR, interquartile range.
Table 5 Subgroup analysis: nutritional and hospitalization parameters based on timing of nasojejunal tube (NJT) placement
Period 1 Period 2 P-value
Routine
intraoperative
NJT
Intraoperative
NJT
Postoperative
NJT
No NJT
(n = 51) (n = 7) (n = 20) (n = 24)
Time to adequate oral intake, days, median (IQR) 12 (10–18) 17 (10–30) 18 (12–30) 6 (4–8) <0.001
Length of stay, days, median (IQR) 18 (12–28) 24 (17–35) 22 (14–42) 9 (7–11) <0.001
P-values shown in bold indicate statistical significance (P < 0.05).
IQR, interquartile range.
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feeding, on outcomes after PD in comparison with routine NJT
feeding.
In conclusion, this observational cohort study demonstrated
that the introduction of an early oral feeding strategy, with
on-demand NJT feeding, reduced the time to resumption of
adequate oral intake and hospital LoS after PD, without having a
negative impact on postoperative morbidity.
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